Skip to main content

Table 1 Baseline characteristics

From: Evaluation of the impact of glycemic status on the progression of coronary artery calcification in asymptomatic individuals

 

Normal (n = 6578)

Pre-diabetes (n = 4146)

Diabetes (n = 1717)

p

Age, years

50 ± 8

53 ± 8*

55 ± 9*†

< 0.001

Male, n (%)

5423 (82.4)

3523 (85.0)

1526 (88.9)

< 0.001

Body mass index, kg/m2

24.1 ± 2.6

25.0 ± 2.8*

25.2 ± 2.9*†

< 0.001

Waist circumference, cm

85 ± 8

88 ± 8*

89 ± 8*†

< 0.001

Systolic blood pressure, mmHg

118 ± 15

122 ± 15*

122 ± 16*

< 0.001

Diastolic blood pressure, mmHg

74 ± 11

77 ± 10*

76 ± 10*

< 0.001

Hypertension, n (%)

1568 (24.4)

1544 (39.1)

924 (55.1)

< 0.001

Antihypertensive drugs, n (%)

984 (17.0)

1077 (30.2)

675 (43.2)

< 0.001

Dyslipidemia, n (%)

1481 (22.6)

1286 (31.0)

701 (40.8)

< 0.001

Lipid lowering drugs, n (%)

89 (4.2)

143 (10.8)

76 (18.8)

< 0.001

Smoking, n (%)

3919 (64.4)

2552 (68.8)

1166 (74.0)

< 0.001

Total cholesterol, mg/dL

196 ± 33

203 ± 34*

190 ± 36*†

< 0.001

Triglyceride, mg/dL

130 ± 79

153 ± 96*

156 ± 102*

< 0.001

HDL cholesterol, mg/dL

54 ± 16

53 ± 16*

51 ± 16*†

< 0.001

LDL cholesterol, mg/dL

122 ± 31

125 ± 33*

115 ± 33*†

< 0.001

Creatinine, mg/dL

0.9 ± 0.2

1.0 ± 0.2

1.0 ± 0.2

0.096

hs-CRP, mg/dL

0.3 ± 1.5

0.4 ± 2.1

0.3 ± 1.7

0.086

Fasting glucose, mg/dL

88 ± 7

100 ± 10*

129 ± 35*†

< 0.001

HbA1C, %

5.3 ± 0.3

5.7 ± 0.3*

6.8 ± 1.1*†

< 0.001

  1. Values are given as mean ± standard deviation or number (%)
  2. HDL high-density lipoprotein, hs-CRP high-sensitivity C-reactive protein, LDL low-density lipoprotein
  3. * p < 0.05 vs. normal, † p < 0.05 vs. pre-diabetes
Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840